
Revolutionizing diagnostic medical imaging with DeepSight™ Technology for safer, faster, and affordable solutions.
DeepSight Technology was founded with the mission to revolutionize diagnostic medical imaging by enhancing the performance of ultrasound technology. Their vision is to make medical imaging safer, faster, more affordable, and more accessible. The company offers products like NeedleVue™, which provides superior visualization of needle tips and other surgical tools within the body, improving both diagnostic and therapeutic procedures. Their market focus is on healthcare providers and medical professionals who require advanced imaging solutions.
Notable affiliated individuals and investors include key figures in medical technology and venture capital, though specific names are not provided. DeepSight Technology has achieved significant milestones in improving the accuracy and efficiency of medical imaging, making a substantial impact on patient care and clinical outcomes. Their innovations have set new standards in the industry, positioning them as leaders in the next generation of ultrasound imaging technology.

Exo
exo.inc

Subtle Medical
subtlemedical.com

DeepTek
deeptek.ai

Delphinus Medical Technologies
delphinusmt.com

Visura Technologies

Verdure Imaging
verdureimaging.com

Lumedica

HeartVista

WaveDyn Vision

nView medical
nviewmed.com

Emagine Solutions Technology

Sanus Solutions
sanussolutions.com

Spectrawave
spectrawave.com

nSight Surgical
nsightsurgical.ai

Visie
visievision.com
Companies similar to DeepSight Technology include Exo, Subtle Medical, DeepTek and Delphinus Medical Technologies.
DeepSight Technology was founded in 2019.
DeepSight Technology's headquarters is located in San Francisco, CA, US.
DeepSight Technology's most recent funding round was for $25M (USD) in October 2021.
As of Oct 11, 2021, DeepSight Technology has raised a total of $25M (USD).
DeepSight Technology has 33 employees as of Feb 4, 2024.